Cargando…

A Review of Early Experience in Lung Ultrasound in the Diagnosis and Management of COVID-19

A novel coronavirus (2019-nCoV) was identified as the cause of a cluster of pneumonia in Wuhan, China, at the end of 2019. Since then more than eight million confirmed cases of coronavirus disease 2019 (COVID-19) have been reported around the globe. The current gold standard for etiologic diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Sultan, Laith R., Sehgal, Chandra M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pergamon Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247506/
https://www.ncbi.nlm.nih.gov/pubmed/32591166
http://dx.doi.org/10.1016/j.ultrasmedbio.2020.05.012
_version_ 1783538170003980288
author Sultan, Laith R.
Sehgal, Chandra M.
author_facet Sultan, Laith R.
Sehgal, Chandra M.
author_sort Sultan, Laith R.
collection PubMed
description A novel coronavirus (2019-nCoV) was identified as the cause of a cluster of pneumonia in Wuhan, China, at the end of 2019. Since then more than eight million confirmed cases of coronavirus disease 2019 (COVID-19) have been reported around the globe. The current gold standard for etiologic diagnosis is reverse transcription–polymerase chain reaction analysis of respiratory-tract specimens, but the test has a high false-negative rate owing to both nasopharyngeal swab sampling error and viral burden. Hence diagnostic imaging has emerged as a fundamental component of current management of COVID-19. Currently, high-resolution computed tomography is the main imaging tool for primary diagnosis and evaluation of disease severity in patients. Lung ultrasound (LUS) imaging has become a safe bedside imaging alternative that does not expose the patient to radiation and minimizes the risk of contamination. Although the number of studies to date is limited, LUS findings have demonstrated high diagnostic sensitivity and accuracy, comparable with those of chest computed tomography scans. In this note we review the current state of the art of LUS in evaluating pulmonary changes induced by COVID-19. The goal is to identify characteristic sonographic findings most suited for the diagnosis of COVID-19 pneumonia infections.
format Online
Article
Text
id pubmed-7247506
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Pergamon Press
record_format MEDLINE/PubMed
spelling pubmed-72475062020-05-26 A Review of Early Experience in Lung Ultrasound in the Diagnosis and Management of COVID-19 Sultan, Laith R. Sehgal, Chandra M. Ultrasound Med Biol Clinical Note A novel coronavirus (2019-nCoV) was identified as the cause of a cluster of pneumonia in Wuhan, China, at the end of 2019. Since then more than eight million confirmed cases of coronavirus disease 2019 (COVID-19) have been reported around the globe. The current gold standard for etiologic diagnosis is reverse transcription–polymerase chain reaction analysis of respiratory-tract specimens, but the test has a high false-negative rate owing to both nasopharyngeal swab sampling error and viral burden. Hence diagnostic imaging has emerged as a fundamental component of current management of COVID-19. Currently, high-resolution computed tomography is the main imaging tool for primary diagnosis and evaluation of disease severity in patients. Lung ultrasound (LUS) imaging has become a safe bedside imaging alternative that does not expose the patient to radiation and minimizes the risk of contamination. Although the number of studies to date is limited, LUS findings have demonstrated high diagnostic sensitivity and accuracy, comparable with those of chest computed tomography scans. In this note we review the current state of the art of LUS in evaluating pulmonary changes induced by COVID-19. The goal is to identify characteristic sonographic findings most suited for the diagnosis of COVID-19 pneumonia infections. Pergamon Press 2020-09 2020-05-25 /pmc/articles/PMC7247506/ /pubmed/32591166 http://dx.doi.org/10.1016/j.ultrasmedbio.2020.05.012 Text en 38; Biology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Clinical Note
Sultan, Laith R.
Sehgal, Chandra M.
A Review of Early Experience in Lung Ultrasound in the Diagnosis and Management of COVID-19
title A Review of Early Experience in Lung Ultrasound in the Diagnosis and Management of COVID-19
title_full A Review of Early Experience in Lung Ultrasound in the Diagnosis and Management of COVID-19
title_fullStr A Review of Early Experience in Lung Ultrasound in the Diagnosis and Management of COVID-19
title_full_unstemmed A Review of Early Experience in Lung Ultrasound in the Diagnosis and Management of COVID-19
title_short A Review of Early Experience in Lung Ultrasound in the Diagnosis and Management of COVID-19
title_sort review of early experience in lung ultrasound in the diagnosis and management of covid-19
topic Clinical Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247506/
https://www.ncbi.nlm.nih.gov/pubmed/32591166
http://dx.doi.org/10.1016/j.ultrasmedbio.2020.05.012
work_keys_str_mv AT sultanlaithr areviewofearlyexperienceinlungultrasoundinthediagnosisandmanagementofcovid19
AT sehgalchandram areviewofearlyexperienceinlungultrasoundinthediagnosisandmanagementofcovid19
AT sultanlaithr reviewofearlyexperienceinlungultrasoundinthediagnosisandmanagementofcovid19
AT sehgalchandram reviewofearlyexperienceinlungultrasoundinthediagnosisandmanagementofcovid19